glp-1 physiology informs the pharmacotherapy of obesity Frontiers Focus on Glucagon-like Peptide-1 Target:

The American Journal of Psychiatry, 152 (7), 10841086

Los GLP-1 (agonistas del receptor del pptido-1 similar al glucagn) son medicamentos prescritos principalmente para que las personas con diabetes de tipo 2 mejoren el control de la glucemia

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

some BPC-157 investigations Rabbits Employed in orthopedic research primarily for BPC-157 Dogs Limited cardiovascular studies for both peptides Cell culture Fibroblasts, endothelial cells, keratinocytes, various tissue-specific lines Human studies NONE for the combination